BLX-155

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBLX-155
Drug Alias NameBLX-155
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionCoagulation factor inhibitorsPlasminogen stimulants
TargetsPlasminogenCoagulation factor
Therapy Area/IndicationsVenous ThrombosisThrombosisPeripheral arterial occlusive disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiolex Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynthon BvBiolex Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsVenous ThrombosisThrombosisPeripheral arterial occlusive disorders

Other Information

ATC CodeN/A
Related LinksN/A